Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper
[Display omitted] The therapeutic armamentarium for the treatment of patients with lymphoproliferative diseases has grown considerably over the most recent years, including a large use of new immunotherapeutic agents. As a consequence, the epidemiology of infectious complications in this group of pa...
Gespeichert in:
| Veröffentlicht in: | Critical reviews in oncology/hematology 2021-02, Vol.158, p.103203-103203, Article 103203 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 103203 |
|---|---|
| container_issue | |
| container_start_page | 103203 |
| container_title | Critical reviews in oncology/hematology |
| container_volume | 158 |
| creator | Busca, Alessandro Cattaneo, Chiara De Carolis, Elena Nadali, Gianpaolo Offidani, Massimo Picardi, Marco Candoni, Anna Ceresoli, Eleonora Criscuolo, Marianna Delia, Mario Della Pepa, Roberta Del Principe, Ilaria Fanci, Roma. Rosa Farina, Francesca Fracchiolla, Nicola Giordano, Claudia Malagola, Michele Marchesi, Francesco Piedimonte, Monica Prezioso, Lucia Quinto, Angela Maria Spolzino, Angelica Tisi, Maria Chiara Trastulli, Fabio Trecarichi, Enrico Maria Zappasodi, Patrizia Tumbarello, Mario Pagano, Livio |
| description | [Display omitted]
The therapeutic armamentarium for the treatment of patients with lymphoproliferative diseases has grown considerably over the most recent years, including a large use of new immunotherapeutic agents. As a consequence, the epidemiology of infectious complications in this group of patients is poorly documented, and even more importantly, the potential benefit of antimicrobial prophylaxis remains a matter of debate when considering the harmful effect from the emergence of multidrug resistant pathogens. The present position paper is addressed to all hematologists treating patients affected by lymphoproliferative malignancies with the aim to provide clinicians with a useful tool for the prevention of bacterial, fungal and viral infections. |
| doi_str_mv | 10.1016/j.critrevonc.2020.103203 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2475087560</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1040842820303395</els_id><sourcerecordid>2475087560</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-3b571d33e60f3c6b39941c7b60ad29354ca88090f098a127f02ae79efbc6d8e13</originalsourceid><addsrcrecordid>eNqFkE2P0zAQhi0EYj_gLyAfuaSMP5I43JaqCyst4gCcLceZ0KmSONhp2f57XLoLR04eWc-8M_MwxgWsBIjq3W7lIy0RD2HyKwny9K0kqGfsUpi6KUBX4nmuQUNhtDQX7CqlHQBoXdUv2YVSyhhdqkv2sA5Tog6jWyhXPEzcTQuN5GNoyQ18jmHeHgf3QInTxOfM4bQk_ouWLR-O47wNGRmo_xNxQN5RQpcwvec3_Ovm7nbzmf-IYT_zOSQ6DckZM8ZX7EXvhoSvH99r9v128239qbj_8vFufXNfeC31Uqi2rEWnFFbQK1-1qmm08HVbgetko0rtnTHQQA-NcULWPUiHdYN966vOoFDX7O05N2_5c49psSMlj8PgJgz7ZKWuSzB1WUFGzRnNt6cUsbdzpNHFoxVgT97tzv7zbk_e7dl7bn3zOGXfjtj9bXwSnYEPZwDzrQfCaJPPIj12FNEvtgv0_ym_AdI0m8o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2475087560</pqid></control><display><type>article</type><title>Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Busca, Alessandro ; Cattaneo, Chiara ; De Carolis, Elena ; Nadali, Gianpaolo ; Offidani, Massimo ; Picardi, Marco ; Candoni, Anna ; Ceresoli, Eleonora ; Criscuolo, Marianna ; Delia, Mario ; Della Pepa, Roberta ; Del Principe, Ilaria ; Fanci, Roma. Rosa ; Farina, Francesca ; Fracchiolla, Nicola ; Giordano, Claudia ; Malagola, Michele ; Marchesi, Francesco ; Piedimonte, Monica ; Prezioso, Lucia ; Quinto, Angela Maria ; Spolzino, Angelica ; Tisi, Maria Chiara ; Trastulli, Fabio ; Trecarichi, Enrico Maria ; Zappasodi, Patrizia ; Tumbarello, Mario ; Pagano, Livio</creator><creatorcontrib>Busca, Alessandro ; Cattaneo, Chiara ; De Carolis, Elena ; Nadali, Gianpaolo ; Offidani, Massimo ; Picardi, Marco ; Candoni, Anna ; Ceresoli, Eleonora ; Criscuolo, Marianna ; Delia, Mario ; Della Pepa, Roberta ; Del Principe, Ilaria ; Fanci, Roma. Rosa ; Farina, Francesca ; Fracchiolla, Nicola ; Giordano, Claudia ; Malagola, Michele ; Marchesi, Francesco ; Piedimonte, Monica ; Prezioso, Lucia ; Quinto, Angela Maria ; Spolzino, Angelica ; Tisi, Maria Chiara ; Trastulli, Fabio ; Trecarichi, Enrico Maria ; Zappasodi, Patrizia ; Tumbarello, Mario ; Pagano, Livio ; on behalf of SEIFEM (Sorveglianza Epidemiologica delle InFezioni nelle EMopatie) ; SEIFEM (Sorveglianza Epidemiologica delle InFezioni nelle EMopatie)</creatorcontrib><description>[Display omitted]
The therapeutic armamentarium for the treatment of patients with lymphoproliferative diseases has grown considerably over the most recent years, including a large use of new immunotherapeutic agents. As a consequence, the epidemiology of infectious complications in this group of patients is poorly documented, and even more importantly, the potential benefit of antimicrobial prophylaxis remains a matter of debate when considering the harmful effect from the emergence of multidrug resistant pathogens. The present position paper is addressed to all hematologists treating patients affected by lymphoproliferative malignancies with the aim to provide clinicians with a useful tool for the prevention of bacterial, fungal and viral infections.</description><identifier>ISSN: 1040-8428</identifier><identifier>EISSN: 1879-0461</identifier><identifier>DOI: 10.1016/j.critrevonc.2020.103203</identifier><identifier>PMID: 33388453</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Anti-Infective Agents - therapeutic use ; Antimicrobial prophylaxis ; Antimicrobial stewardship ; Bacterial ; Fungal and viral infections ; Humans ; Lymphoproliferative disorders ; Lymphoproliferative Disorders - drug therapy ; Lymphoproliferative Disorders - epidemiology ; Lymphoproliferative Disorders - etiology</subject><ispartof>Critical reviews in oncology/hematology, 2021-02, Vol.158, p.103203-103203, Article 103203</ispartof><rights>2020</rights><rights>Copyright © 2020. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-3b571d33e60f3c6b39941c7b60ad29354ca88090f098a127f02ae79efbc6d8e13</citedby><cites>FETCH-LOGICAL-c424t-3b571d33e60f3c6b39941c7b60ad29354ca88090f098a127f02ae79efbc6d8e13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.critrevonc.2020.103203$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33388453$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Busca, Alessandro</creatorcontrib><creatorcontrib>Cattaneo, Chiara</creatorcontrib><creatorcontrib>De Carolis, Elena</creatorcontrib><creatorcontrib>Nadali, Gianpaolo</creatorcontrib><creatorcontrib>Offidani, Massimo</creatorcontrib><creatorcontrib>Picardi, Marco</creatorcontrib><creatorcontrib>Candoni, Anna</creatorcontrib><creatorcontrib>Ceresoli, Eleonora</creatorcontrib><creatorcontrib>Criscuolo, Marianna</creatorcontrib><creatorcontrib>Delia, Mario</creatorcontrib><creatorcontrib>Della Pepa, Roberta</creatorcontrib><creatorcontrib>Del Principe, Ilaria</creatorcontrib><creatorcontrib>Fanci, Roma. Rosa</creatorcontrib><creatorcontrib>Farina, Francesca</creatorcontrib><creatorcontrib>Fracchiolla, Nicola</creatorcontrib><creatorcontrib>Giordano, Claudia</creatorcontrib><creatorcontrib>Malagola, Michele</creatorcontrib><creatorcontrib>Marchesi, Francesco</creatorcontrib><creatorcontrib>Piedimonte, Monica</creatorcontrib><creatorcontrib>Prezioso, Lucia</creatorcontrib><creatorcontrib>Quinto, Angela Maria</creatorcontrib><creatorcontrib>Spolzino, Angelica</creatorcontrib><creatorcontrib>Tisi, Maria Chiara</creatorcontrib><creatorcontrib>Trastulli, Fabio</creatorcontrib><creatorcontrib>Trecarichi, Enrico Maria</creatorcontrib><creatorcontrib>Zappasodi, Patrizia</creatorcontrib><creatorcontrib>Tumbarello, Mario</creatorcontrib><creatorcontrib>Pagano, Livio</creatorcontrib><creatorcontrib>on behalf of SEIFEM (Sorveglianza Epidemiologica delle InFezioni nelle EMopatie)</creatorcontrib><creatorcontrib>SEIFEM (Sorveglianza Epidemiologica delle InFezioni nelle EMopatie)</creatorcontrib><title>Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper</title><title>Critical reviews in oncology/hematology</title><addtitle>Crit Rev Oncol Hematol</addtitle><description>[Display omitted]
The therapeutic armamentarium for the treatment of patients with lymphoproliferative diseases has grown considerably over the most recent years, including a large use of new immunotherapeutic agents. As a consequence, the epidemiology of infectious complications in this group of patients is poorly documented, and even more importantly, the potential benefit of antimicrobial prophylaxis remains a matter of debate when considering the harmful effect from the emergence of multidrug resistant pathogens. The present position paper is addressed to all hematologists treating patients affected by lymphoproliferative malignancies with the aim to provide clinicians with a useful tool for the prevention of bacterial, fungal and viral infections.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Antimicrobial prophylaxis</subject><subject>Antimicrobial stewardship</subject><subject>Bacterial</subject><subject>Fungal and viral infections</subject><subject>Humans</subject><subject>Lymphoproliferative disorders</subject><subject>Lymphoproliferative Disorders - drug therapy</subject><subject>Lymphoproliferative Disorders - epidemiology</subject><subject>Lymphoproliferative Disorders - etiology</subject><issn>1040-8428</issn><issn>1879-0461</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE2P0zAQhi0EYj_gLyAfuaSMP5I43JaqCyst4gCcLceZ0KmSONhp2f57XLoLR04eWc-8M_MwxgWsBIjq3W7lIy0RD2HyKwny9K0kqGfsUpi6KUBX4nmuQUNhtDQX7CqlHQBoXdUv2YVSyhhdqkv2sA5Tog6jWyhXPEzcTQuN5GNoyQ18jmHeHgf3QInTxOfM4bQk_ouWLR-O47wNGRmo_xNxQN5RQpcwvec3_Ovm7nbzmf-IYT_zOSQ6DckZM8ZX7EXvhoSvH99r9v128239qbj_8vFufXNfeC31Uqi2rEWnFFbQK1-1qmm08HVbgetko0rtnTHQQA-NcULWPUiHdYN966vOoFDX7O05N2_5c49psSMlj8PgJgz7ZKWuSzB1WUFGzRnNt6cUsbdzpNHFoxVgT97tzv7zbk_e7dl7bn3zOGXfjtj9bXwSnYEPZwDzrQfCaJPPIj12FNEvtgv0_ym_AdI0m8o</recordid><startdate>202102</startdate><enddate>202102</enddate><creator>Busca, Alessandro</creator><creator>Cattaneo, Chiara</creator><creator>De Carolis, Elena</creator><creator>Nadali, Gianpaolo</creator><creator>Offidani, Massimo</creator><creator>Picardi, Marco</creator><creator>Candoni, Anna</creator><creator>Ceresoli, Eleonora</creator><creator>Criscuolo, Marianna</creator><creator>Delia, Mario</creator><creator>Della Pepa, Roberta</creator><creator>Del Principe, Ilaria</creator><creator>Fanci, Roma. Rosa</creator><creator>Farina, Francesca</creator><creator>Fracchiolla, Nicola</creator><creator>Giordano, Claudia</creator><creator>Malagola, Michele</creator><creator>Marchesi, Francesco</creator><creator>Piedimonte, Monica</creator><creator>Prezioso, Lucia</creator><creator>Quinto, Angela Maria</creator><creator>Spolzino, Angelica</creator><creator>Tisi, Maria Chiara</creator><creator>Trastulli, Fabio</creator><creator>Trecarichi, Enrico Maria</creator><creator>Zappasodi, Patrizia</creator><creator>Tumbarello, Mario</creator><creator>Pagano, Livio</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202102</creationdate><title>Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper</title><author>Busca, Alessandro ; Cattaneo, Chiara ; De Carolis, Elena ; Nadali, Gianpaolo ; Offidani, Massimo ; Picardi, Marco ; Candoni, Anna ; Ceresoli, Eleonora ; Criscuolo, Marianna ; Delia, Mario ; Della Pepa, Roberta ; Del Principe, Ilaria ; Fanci, Roma. Rosa ; Farina, Francesca ; Fracchiolla, Nicola ; Giordano, Claudia ; Malagola, Michele ; Marchesi, Francesco ; Piedimonte, Monica ; Prezioso, Lucia ; Quinto, Angela Maria ; Spolzino, Angelica ; Tisi, Maria Chiara ; Trastulli, Fabio ; Trecarichi, Enrico Maria ; Zappasodi, Patrizia ; Tumbarello, Mario ; Pagano, Livio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-3b571d33e60f3c6b39941c7b60ad29354ca88090f098a127f02ae79efbc6d8e13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Antimicrobial prophylaxis</topic><topic>Antimicrobial stewardship</topic><topic>Bacterial</topic><topic>Fungal and viral infections</topic><topic>Humans</topic><topic>Lymphoproliferative disorders</topic><topic>Lymphoproliferative Disorders - drug therapy</topic><topic>Lymphoproliferative Disorders - epidemiology</topic><topic>Lymphoproliferative Disorders - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Busca, Alessandro</creatorcontrib><creatorcontrib>Cattaneo, Chiara</creatorcontrib><creatorcontrib>De Carolis, Elena</creatorcontrib><creatorcontrib>Nadali, Gianpaolo</creatorcontrib><creatorcontrib>Offidani, Massimo</creatorcontrib><creatorcontrib>Picardi, Marco</creatorcontrib><creatorcontrib>Candoni, Anna</creatorcontrib><creatorcontrib>Ceresoli, Eleonora</creatorcontrib><creatorcontrib>Criscuolo, Marianna</creatorcontrib><creatorcontrib>Delia, Mario</creatorcontrib><creatorcontrib>Della Pepa, Roberta</creatorcontrib><creatorcontrib>Del Principe, Ilaria</creatorcontrib><creatorcontrib>Fanci, Roma. Rosa</creatorcontrib><creatorcontrib>Farina, Francesca</creatorcontrib><creatorcontrib>Fracchiolla, Nicola</creatorcontrib><creatorcontrib>Giordano, Claudia</creatorcontrib><creatorcontrib>Malagola, Michele</creatorcontrib><creatorcontrib>Marchesi, Francesco</creatorcontrib><creatorcontrib>Piedimonte, Monica</creatorcontrib><creatorcontrib>Prezioso, Lucia</creatorcontrib><creatorcontrib>Quinto, Angela Maria</creatorcontrib><creatorcontrib>Spolzino, Angelica</creatorcontrib><creatorcontrib>Tisi, Maria Chiara</creatorcontrib><creatorcontrib>Trastulli, Fabio</creatorcontrib><creatorcontrib>Trecarichi, Enrico Maria</creatorcontrib><creatorcontrib>Zappasodi, Patrizia</creatorcontrib><creatorcontrib>Tumbarello, Mario</creatorcontrib><creatorcontrib>Pagano, Livio</creatorcontrib><creatorcontrib>on behalf of SEIFEM (Sorveglianza Epidemiologica delle InFezioni nelle EMopatie)</creatorcontrib><creatorcontrib>SEIFEM (Sorveglianza Epidemiologica delle InFezioni nelle EMopatie)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Critical reviews in oncology/hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Busca, Alessandro</au><au>Cattaneo, Chiara</au><au>De Carolis, Elena</au><au>Nadali, Gianpaolo</au><au>Offidani, Massimo</au><au>Picardi, Marco</au><au>Candoni, Anna</au><au>Ceresoli, Eleonora</au><au>Criscuolo, Marianna</au><au>Delia, Mario</au><au>Della Pepa, Roberta</au><au>Del Principe, Ilaria</au><au>Fanci, Roma. Rosa</au><au>Farina, Francesca</au><au>Fracchiolla, Nicola</au><au>Giordano, Claudia</au><au>Malagola, Michele</au><au>Marchesi, Francesco</au><au>Piedimonte, Monica</au><au>Prezioso, Lucia</au><au>Quinto, Angela Maria</au><au>Spolzino, Angelica</au><au>Tisi, Maria Chiara</au><au>Trastulli, Fabio</au><au>Trecarichi, Enrico Maria</au><au>Zappasodi, Patrizia</au><au>Tumbarello, Mario</au><au>Pagano, Livio</au><aucorp>on behalf of SEIFEM (Sorveglianza Epidemiologica delle InFezioni nelle EMopatie)</aucorp><aucorp>SEIFEM (Sorveglianza Epidemiologica delle InFezioni nelle EMopatie)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper</atitle><jtitle>Critical reviews in oncology/hematology</jtitle><addtitle>Crit Rev Oncol Hematol</addtitle><date>2021-02</date><risdate>2021</risdate><volume>158</volume><spage>103203</spage><epage>103203</epage><pages>103203-103203</pages><artnum>103203</artnum><issn>1040-8428</issn><eissn>1879-0461</eissn><abstract>[Display omitted]
The therapeutic armamentarium for the treatment of patients with lymphoproliferative diseases has grown considerably over the most recent years, including a large use of new immunotherapeutic agents. As a consequence, the epidemiology of infectious complications in this group of patients is poorly documented, and even more importantly, the potential benefit of antimicrobial prophylaxis remains a matter of debate when considering the harmful effect from the emergence of multidrug resistant pathogens. The present position paper is addressed to all hematologists treating patients affected by lymphoproliferative malignancies with the aim to provide clinicians with a useful tool for the prevention of bacterial, fungal and viral infections.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>33388453</pmid><doi>10.1016/j.critrevonc.2020.103203</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1040-8428 |
| ispartof | Critical reviews in oncology/hematology, 2021-02, Vol.158, p.103203-103203, Article 103203 |
| issn | 1040-8428 1879-0461 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2475087560 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Anti-Bacterial Agents - therapeutic use Anti-Infective Agents - therapeutic use Antimicrobial prophylaxis Antimicrobial stewardship Bacterial Fungal and viral infections Humans Lymphoproliferative disorders Lymphoproliferative Disorders - drug therapy Lymphoproliferative Disorders - epidemiology Lymphoproliferative Disorders - etiology |
| title | Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T02%3A58%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Considerations%20on%20antimicrobial%20prophylaxis%20in%20patients%20with%20lymphoproliferative%20diseases:%20A%20SEIFEM%20group%20position%20paper&rft.jtitle=Critical%20reviews%20in%20oncology/hematology&rft.au=Busca,%20Alessandro&rft.aucorp=on%20behalf%20of%20SEIFEM%20(Sorveglianza%20Epidemiologica%20delle%20InFezioni%20nelle%20EMopatie)&rft.date=2021-02&rft.volume=158&rft.spage=103203&rft.epage=103203&rft.pages=103203-103203&rft.artnum=103203&rft.issn=1040-8428&rft.eissn=1879-0461&rft_id=info:doi/10.1016/j.critrevonc.2020.103203&rft_dat=%3Cproquest_cross%3E2475087560%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2475087560&rft_id=info:pmid/33388453&rft_els_id=S1040842820303395&rfr_iscdi=true |